Table of Contents Global Sustained Release Ocular Drug Delivery Systems Market Research Report 2020, Forecast to 2025 1 Market Overview 1.1 Sustained Release Ocular Drug Delivery Systems Definition 1.1.1 Analysis of Macroeconomic Indicators 1.1.2 Years Considered 1.2 Sustained Release Ocular Drug Delivery Systems Segment by Type 1.2.1 Liposome 1.2.2 Microcapsules/Nanocapsules 1.2.3 Microspheres/Nanosptheres 1.2.4 Implants 1.3 Market Analysis by Application 1.3.1 Cataract 1.3.2 Glaucoma 1.3.3 Corneal Transplantation 1.3.4 Others 1.4 Overview of Global Sustained Release Ocular Drug Delivery Systems Market 1.4.1 Global Sustained Release Ocular Drug Delivery Systems Revenue (2015-2025) 1.4.2 Global Sustained Release Ocular Drug Delivery Systems Production and Capacity (2015-2025) 1.4.3 North America Sustained Release Ocular Drug Delivery Systems Status and Prospect (2015-2025) 1.4.4 Europe Sustained Release Ocular Drug Delivery Systems Status and Prospect (2015-2025) 1.4.5 Japan Sustained Release Ocular Drug Delivery Systems Status and Prospect (2014-2025) 1.4.6 China Sustained Release Ocular Drug Delivery Systems Status and Prospect (2015-2025) 1.5 Market Dynamics 1.5.1 Market Opportunities 1.5.2 Market Risk 1.5.3 Market Driving Force 1.5.4 Porter's Five Forces Analysis 1.5.5 SWOT Analysis 1.6 Coronavirus Disease 2019 (Covid-19): Sustained Release Ocular Drug Delivery Systems Industry Impact 1.6.1 How the Covid-19 is Affecting the Sustained Release Ocular Drug Delivery Systems Industry 1.6.2 Sustained Release Ocular Drug Delivery Systems Business Impact Assessment - Covid-19 1.6.3 Market Trends and Sustained Release Ocular Drug Delivery Systems Potential Opportunities in the COVID-19 Landscape 1.6.4 Measures / Proposal against Covid-19 2 Global Sustained Release Ocular Drug Delivery Systems Market Competition by Manufacturer 2.1 Global Sustained Release Ocular Drug Delivery Systems Sales and Market Share by Manufacturer (2018-2020) 2.2 Global Sustained Release Ocular Drug Delivery Systems Revenue and Market Share by Manufacturer (2018-2020) 2.3 Global Sustained Release Ocular Drug Delivery Systems Industry Concentration Ratio (CR5 and HHI) 2.4 Top 5 Sustained Release Ocular Drug Delivery Systems Manufacturer Market Share 2.5 Top 10 Sustained Release Ocular Drug Delivery Systems Manufacturer Market Share 2.6 Date of Key Manufacturers Enter into Sustained Release Ocular Drug Delivery Systems Market 2.7 Key Manufacturers Sustained Release Ocular Drug Delivery Systems Product Offered 2.8 Mergers & Acquisitions Planning 3 Analysis of Sustained Release Ocular Drug Delivery Systems Industry Key Manufacturers 3.1 pSivida 3.1.1 Company Details 3.1.2 Product Information 3.1.3 pSivida Sustained Release Ocular Drug Delivery Systems Production, Price, Cost, Gross Margin, and Revenue (2018-2020) 3.1.4 Main Business Overview 3.1.5 pSivida News 3.2 Allergan 3.2.1 Company Details 3.2.2 Product Information 3.2.3 Allergan Sustained Release Ocular Drug Delivery Systems Production, Price, Cost, Gross Margin, and Revenue (2018-2020) 3.2.4 Main Business Overview 3.2.5 Allergan News 3.3 Icon Bioscience 3.3.1 Company Details 3.3.2 Product Information 3.3.3 Icon Bioscience Sustained Release Ocular Drug Delivery Systems Production, Price, Cost, Gross Margin, and Revenue (2018-2020) 3.3.4 Main Business Overview 3.3.5 Icon Bioscience News 3.4 Ocular Therapeutix 3.4.1 Company Details 3.4.2 Product Information 3.4.3 Ocular Therapeutix Sustained Release Ocular Drug Delivery Systems Production, Price, Cost, Gross Margin, and Revenue (2018-2020) 3.4.4 Main Business Overview 3.4.5 Ocular Therapeutix News 3.5 Neurotech Pharmaceuticals 3.5.1 Company Details 3.5.2 Product Information 3.5.3 Neurotech Pharmaceuticals Sustained Release Ocular Drug Delivery Systems Production, Price, Cost, Gross Margin, and Revenue (2018-2020) 3.5.4 Main Business Overview 3.5.5 Neurotech Pharmaceuticals News 3.6 Santen Pharmaceutical 3.6.1 Company Details 3.6.2 Product Information 3.6.3 Santen Pharmaceutical Sustained Release Ocular Drug Delivery Systems Production, Price, Cost, Gross Margin, and Revenue (2018-2020) 3.6.4 Main Business Overview 3.6.5 Santen Pharmaceutical News 3.7 Aciont Inc. 3.7.1 Company Details 3.7.2 Product Information 3.7.3 Aciont Inc. Sustained Release Ocular Drug Delivery Systems Production, Price, Cost, Gross Margin, and Revenue (2018-2020) 3.7.4 Main Business Overview 3.7.5 Aciont Inc. News 3.8 Envisia Therapeutics 3.8.1 Company Details 3.8.2 Product Information 3.8.3 Envisia Therapeutics Sustained Release Ocular Drug Delivery Systems Production, Price, Cost, Gross Margin, and Revenue (2018-2020) 3.8.4 Main Business Overview 3.8.5 Envisia Therapeutics News 3.9 GrayBug 3.9.1 Company Details 3.9.2 Product Information 3.9.3 GrayBug Sustained Release Ocular Drug Delivery Systems Production, Price, Cost, Gross Margin, and Revenue (2018-2020) 3.9.4 Main Business Overview 3.9.5 GrayBug News 3.10 Innocore Pharmaceuticals 3.10.1 Company Details 3.10.2 Product Information 3.10.3 Innocore Pharmaceuticals Sustained Release Ocular Drug Delivery Systems Production, Price, Cost, Gross Margin, and Revenue (2018-2020) 3.10.4 Main Business Overview 3.10.5 Innocore Pharmaceuticals News 3.11 OHR Pharmaceuticals 3.11.1 Company Details 3.11.2 Product Information 3.11.3 OHR Pharmaceuticals Sustained Release Ocular Drug Delivery Systems Production, Price, Cost, Gross Margin, and Revenue (2018-2020) 3.11.4 Main Business Overview 3.11.5 OHR Pharmaceuticals News 3.12 PolyActiva 3.12.1 Company Details 3.12.2 Product Information 3.12.3 PolyActiva Sustained Release Ocular Drug Delivery Systems Production, Price, Cost, Gross Margin, and Revenue (2018-2020) 3.12.4 Main Business Overview 3.12.5 PolyActiva News 3.13 TheraKine 3.13.1 Company Details 3.13.2 Product Information 3.13.3 TheraKine Sustained Release Ocular Drug Delivery Systems Production, Price, Cost, Gross Margin, and Revenue (2018-2020) 3.13.4 Main Business Overview 3.13.5 TheraKine News 4 Global Sustained Release Ocular Drug Delivery Systems Market Size Categorized by Regions (2015-2020) 4.1 Global Sustained Release Ocular Drug Delivery Systems Sales Market Share by Region 4.2 Global Sustained Release Ocular Drug Delivery Systems Revenue Market Share by Region (2015-2019) 4.3 Global Sustained Release Ocular Drug Delivery Systems Sales, Revenue, Price and Gross Margin (2015-2020) 4.4 North America Sustained Release Ocular Drug Delivery Systems Market Size Detail 4.4.1 North America Sustained Release Ocular Drug Delivery Systems Sales Growth Rate (2015-2020) 4.4.2 North America Sustained Release Ocular Drug Delivery Systems Sales, Revenue, Price and Gross Margin (2015-2020) 4.5 Europe Sustained Release Ocular Drug Delivery Systems Market Size Detail 4.5.1 Europe Sustained Release Ocular Drug Delivery Systems Sales Growth Rate (2015-2020) 4.5.2 Europe Sustained Release Ocular Drug Delivery Systems Sales, Revenue, Price and Gross Margin (2015-2020) 4.6 Japan Sustained Release Ocular Drug Delivery Systems Market Size Detail 4.6.1 Japan Sustained Release Ocular Drug Delivery Systems Sales Growth Rate (2015-2020) 4.6.2 Japan Sustained Release Ocular Drug Delivery Systems Sales, Revenue, Price and Gross Margin (2015-2020) 4.7 China Sustained Release Ocular Drug Delivery Systems Market Size Detail 4.7.1 China Sustained Release Ocular Drug Delivery Systems Sales Growth Rate (2015-2020) 4.7.2 China Sustained Release Ocular Drug Delivery Systems Sales, Revenue, Price and Gross Margin (2015-2020) 5 Global Sustained Release Ocular Drug Delivery Systems Market Segment by Type 5.1 Global Sustained Release Ocular Drug Delivery Systems Revenue, Sales and Market Share by Type (2015-2020) 5.1.1 Global Sustained Release Ocular Drug Delivery Systems Sales and Market Share by Type (2015-2020) 5.1.2 Global Sustained Release Ocular Drug Delivery Systems Revenue and Market Share by Type (2015-2020) 5.2 Liposome Sales Growth Rate and Price 5.2.1 Global Liposome Sales Growth Rate (2015-2020) 5.2.2 Global Liposome Price (2015-2020) 5.3 Microcapsules/Nanocapsules Sales Growth Rate and Price 5.3.1 Global Microcapsules/Nanocapsules Sales Growth Rate (2015-2020) 5.3.2 Global Microcapsules/Nanocapsules Price (2015-2020) 5.4 Microspheres/Nanosptheres Sales Growth Rate and Price 5.4.1 Global Microspheres/Nanosptheres Sales Growth Rate (2015-2020) 5.4.2 Global Microspheres/Nanosptheres Price (2015-2020) 5.5 Implants Sales Growth Rate and Price 5.5.1 Global Implants Sales Growth Rate (2015-2020) 5.5.2 Global Implants Price (2015-2020) 6 Global Sustained Release Ocular Drug Delivery Systems Market Segment by Application 6.1 Global Sustained Release Ocular Drug Delivery Systems Sales Market Share by Application (2015-2020) 6.2 Cataract Sales Growth Rate (2015-2020) 6.3 Glaucoma Sales Growth Rate (2015-2020) 6.4 Corneal Transplantation Sales Growth Rate (2015-2020) 6.5 Others Sales Growth Rate (2015-2020) 7 Sustained Release Ocular Drug Delivery Systems Related Market Analysis 7.1 Upstream Analysis 7.1.1 Macro Analysis of Upstream Markets 7.1.2 Key Players in Upstream Markets 7.1.3 Upstream Market Trend Analysis 7.1.4 Sustained Release Ocular Drug Delivery Systems Manufacturing Cost Analysis 7.2 Downstream Market Analysis 7.2.1 Macro Analysis of Down Markets 7.2.2 Key Players in Down Markets 7.2.3 Downstream Market Trend Analysis 7.2.4 Sales Channel, Distributors, Traders and Dealers 8 Global Sustained Release Ocular Drug Delivery Systems Market Forecast 8.1 Global Sustained Release Ocular Drug Delivery Systems Sales, Revenue Forecast 8.1.1 Global Sustained Release Ocular Drug Delivery Systems Sales Growth Rate Forecast (2020-2025) 8.1.2 Global Sustained Release Ocular Drug Delivery Systems Revenue and Growth Rate Forecast (2020-2025) 8.1.3 Global Sustained Release Ocular Drug Delivery Systems Price and Trend Forecast (2020-2025) 8.2 Global Sustained Release Ocular Drug Delivery Systems Sales Forecast by Region (2020-2025) 8.2.1 North America Sustained Release Ocular Drug Delivery Systems Sales, Revenue Forecast (2020-2025) 8.2.2 Europe Sustained Release Ocular Drug Delivery Systems Sales, Revenue Forecast (2020-2025) 8.2.3 Japan Sustained Release Ocular Drug Delivery Systems Production, Revenue Forecast (2020-2025) 8.2.4 China Sustained Release Ocular Drug Delivery Systems Production, Revenue Forecast (2020-2025) 9 Research Findings and Conclusion 10 Appendix

List of Tables and Figures Figure Sustained Release Ocular Drug Delivery Systems Picture Table Global Sustained Release Ocular Drug Delivery Systems Sales by Type Figure Global Sales Market Share of Sustained Release Ocular Drug Delivery Systems by Product Type in 2019 Table Breakdown of Sustained Release Ocular Drug Delivery Systems by Company Type (Tier 1, Tier 2 and Tier 3) Figure Sustained Release Ocular Drug Delivery Systems Market Share by Company Type (Tier 1, Tier 2 and Tier 3) Figure Liposome Picture Figure Microcapsules/Nanocapsules Picture Figure Microspheres/Nanosptheres Picture Figure Implants Picture Table Global Sustained Release Ocular Drug Delivery Systems Sales by Application Figure Global Sustained Release Ocular Drug Delivery Systems Sales Market Share by Application in 2019 Figure Cataract Picture Figure Glaucoma Picture Figure Corneal Transplantation Picture Figure Others Picture Table Sustained Release Ocular Drug Delivery Systems Market Size Comparison by Region (2019-2025) (K Units) & (Million US$) Figure Global Sustained Release Ocular Drug Delivery Systems Revenue (Million US$) (2015-2025) Figure Global Sustained Release Ocular Drug Delivery Systems Production (K Units) (2015-2025) Figure North America Sustained Release Ocular Drug Delivery Systems Revenue (Million US$) Growth Rate (2015-2025) Figure Europe Sustained Release Ocular Drug Delivery Systems Revenue (Million US$) Growth Rate (2015-2025) Figure Japan Sustained Release Ocular Drug Delivery Systems Revenue (Million US$) Growth Rate (2014-2025) Figure China Sustained Release Ocular Drug Delivery Systems Revenue (Million US$) Growth Rate (2015-2025) Table Market Opportunities in Next Few Years Table Market Risks Analysis Table Market Drivers Figure Porter's Five Forces Analysis Table SWOT Analysis Table Global Sustained Release Ocular Drug Delivery Systems Sales by Manufacturer (2018-2020) Figure Global Sustained Release Ocular Drug Delivery Systems Sales Market Share by Manufacturer in 2019 Table Global Sustained Release Ocular Drug Delivery Systems Revenue by Manufacturer (2018-2020) Figure Global Sustained Release Ocular Drug Delivery Systems Revenue Market Share by Manufacturer in 2019 Table Global Sustained Release Ocular Drug Delivery Systems Manufacturers Market Concentration Ratio (CR5 and HHI) Figure Top 5 Sustained Release Ocular Drug Delivery Systems Manufacturer (Revenue) Market Share in 2019 Figure Top 10 Sustained Release Ocular Drug Delivery Systems Manufacturer (Revenue) Market Share in 2019 Table Date of Key Manufacturers Enter into Sustained Release Ocular Drug Delivery Systems Market Table Key Manufacturers Sustained Release Ocular Drug Delivery Systems Product Type Table Mergers & Acquisitions Planning Table pSivida Company Profile Figure Sustained Release Ocular Drug Delivery Systems Product Picture and Specifications of pSivida Table Sustained Release Ocular Drug Delivery Systems Production, Price, Revenue and Gross Margin of 2018-2020 Figure pSivida Sustained Release Ocular Drug Delivery Systems Market Share (2018-2020) Table pSivida Main Business Table pSivida Recent Development Table Allergan Company Profile Figure Sustained Release Ocular Drug Delivery Systems Product Picture and Specifications of Allergan Table Sustained Release Ocular Drug Delivery Systems Production, Price, Revenue and Gross Margin of 2018-2020 Figure Allergan Sustained Release Ocular Drug Delivery Systems Market Share (2018-2020) Table Allergan Main Business Table Allergan Recent Development Table Icon Bioscience Company Profile Figure Sustained Release Ocular Drug Delivery Systems Product Picture and Specifications of Icon Bioscience Table Sustained Release Ocular Drug Delivery Systems Production, Price, Revenue and Gross Margin of 2018-2020 Figure Icon Bioscience Sustained Release Ocular Drug Delivery Systems Market Share (2018-2020) Table Icon Bioscience Main Business Table Icon Bioscience Recent Development Table Ocular Therapeutix Company Profile Figure Sustained Release Ocular Drug Delivery Systems Product Picture and Specifications of Ocular Therapeutix Table Sustained Release Ocular Drug Delivery Systems Production, Price, Revenue and Gross Margin of 2018-2020 Figure Ocular Therapeutix Sustained Release Ocular Drug Delivery Systems Market Share (2018-2020) Table Ocular Therapeutix Main Business Table Ocular Therapeutix Recent Development Table Neurotech Pharmaceuticals Company Profile Figure Sustained Release Ocular Drug Delivery Systems Product Picture and Specifications of Neurotech Pharmaceuticals Table Sustained Release Ocular Drug Delivery Systems Production, Price, Revenue and Gross Margin of 2018-2020 Figure Neurotech Pharmaceuticals Sustained Release Ocular Drug Delivery Systems Market Share (2018-2020) Table Neurotech Pharmaceuticals Main Business Table Neurotech Pharmaceuticals Recent Development Table Santen Pharmaceutical Company Profile Figure Sustained Release Ocular Drug Delivery Systems Product Picture and Specifications of Santen Pharmaceutical Table Sustained Release Ocular Drug Delivery Systems Production, Price, Revenue and Gross Margin of 2018-2020 Figure Santen Pharmaceutical Sustained Release Ocular Drug Delivery Systems Market Share (2018-2020) Table Santen Pharmaceutical Main Business Table Santen Pharmaceutical Recent Development Table Aciont Inc. Company Profile Figure Sustained Release Ocular Drug Delivery Systems Product Picture and Specifications of Aciont Inc. Table Sustained Release Ocular Drug Delivery Systems Production, Price, Revenue and Gross Margin of 2018-2020 Figure Aciont Inc. Sustained Release Ocular Drug Delivery Systems Market Share (2018-2020) Table Aciont Inc. Main Business Table Aciont Inc. Recent Development Table Envisia Therapeutics Company Profile Figure Sustained Release Ocular Drug Delivery Systems Product Picture and Specifications of Envisia Therapeutics Table Sustained Release Ocular Drug Delivery Systems Production, Price, Revenue and Gross Margin of 2018-2020 Figure Envisia Therapeutics Sustained Release Ocular Drug Delivery Systems Market Share (2018-2020) Table Envisia Therapeutics Main Business Table Envisia Therapeutics Recent Development Table GrayBug Company Profile Figure Sustained Release Ocular Drug Delivery Systems Product Picture and Specifications of GrayBug Table Sustained Release Ocular Drug Delivery Systems Production, Price, Revenue and Gross Margin of 2018-2020 Figure GrayBug Sustained Release Ocular Drug Delivery Systems Market Share (2018-2020) Table GrayBug Main Business Table GrayBug Recent Development Table Innocore Pharmaceuticals Company Profile Figure Sustained Release Ocular Drug Delivery Systems Product Picture and Specifications of Innocore Pharmaceuticals Table Sustained Release Ocular Drug Delivery Systems Production, Price, Revenue and Gross Margin of 2018-2020 Figure Innocore Pharmaceuticals Sustained Release Ocular Drug Delivery Systems Market Share (2018-2020) Table Innocore Pharmaceuticals Main Business Table Innocore Pharmaceuticals Recent Development Table OHR Pharmaceuticals Company Profile Figure Sustained Release Ocular Drug Delivery Systems Product Picture and Specifications of OHR Pharmaceuticals Table Sustained Release Ocular Drug Delivery Systems Production, Price, Revenue and Gross Margin of 2018-2020 Figure OHR Pharmaceuticals Sustained Release Ocular Drug Delivery Systems Market Share (2018-2020) Table OHR Pharmaceuticals Main Business Table OHR Pharmaceuticals Recent Development Table PolyActiva Company Profile Figure Sustained Release Ocular Drug Delivery Systems Product Picture and Specifications of PolyActiva Table Sustained Release Ocular Drug Delivery Systems Production, Price, Revenue and Gross Margin of 2018-2020 Figure PolyActiva Sustained Release Ocular Drug Delivery Systems Market Share (2018-2020) Table PolyActiva Main Business Table PolyActiva Recent Development Table TheraKine Company Profile Figure Sustained Release Ocular Drug Delivery Systems Product Picture and Specifications of TheraKine Table Sustained Release Ocular Drug Delivery Systems Production, Price, Revenue and Gross Margin of 2018-2020 Figure TheraKine Sustained Release Ocular Drug Delivery Systems Market Share (2018-2020) Table TheraKine Main Business Table TheraKine Recent Development Table Global Sustained Release Ocular Drug Delivery Systems Sales (K Units) by Region (2015-2020) Table Global Sustained Release Ocular Drug Delivery Systems Sales Market Share by Region (2015-2019) Figure Global Sustained Release Ocular Drug Delivery Systems Sales Market Share by Region (2015-2019) Figure Global Sustained Release Ocular Drug Delivery Systems Sales Market Share by Region in 2018 Table Global Sustained Release Ocular Drug Delivery Systems Revenue (Million US$) by Region (2015-2020) Table Global Sustained Release Ocular Drug Delivery Systems Revenue Market Share by Region (2015-2020) Figure Global Sustained Release Ocular Drug Delivery Systems Revenue Market Share by Region (2015-2020) Figure Global Sustained Release Ocular Drug Delivery Systems Revenue Market Share by Region in 2019 Table Global Sustained Release Ocular Drug Delivery Systems Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2015-2020) Figure North America Sustained Release Ocular Drug Delivery Systems Sales (K Units) Growth Rate (2015-2020) Figure Europe Sustained Release Ocular Drug Delivery Systems Sales (K Units) Growth Rate (2015-2020) Table Europe Sustained Release Ocular Drug Delivery Systems Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2015-2020) Figure Japan Sustained Release Ocular Drug Delivery Systems Sales (K Units) Growth Rate (2015-2020) Table Japan Sustained Release Ocular Drug Delivery Systems Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2015-2020) Figure China Sustained Release Ocular Drug Delivery Systems Sales (K Units) Growth Rate (2015-2020) Table China Sustained Release Ocular Drug Delivery Systems Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2015-2020) Table Global Sustained Release Ocular Drug Delivery Systems Sales by Type (2015-2020) Table Global Sustained Release Ocular Drug Delivery Systems Sales Market Share by Type (2015-2020) Figure Global Sustained Release Ocular Drug Delivery Systems Sales Market Share by Type in 2019 Table Global Sustained Release Ocular Drug Delivery Systems Revenue by Type (2015-2020) Table Global Sustained Release Ocular Drug Delivery Systems Revenue Market Share by Type (2015-2020) Figure Global Sustained Release Ocular Drug Delivery Systems Revenue Market Share by Type in 2019 Figure Global Liposome Sales Growth Rate (2015-2025) Figure Global Liposome Price (2015-2020) Figure Global Microcapsules/Nanocapsules Sales Growth Rate (2015-2025) Figure Global Microcapsules/Nanocapsules Price (2015-2020) Figure Global Microspheres/Nanosptheres Sales Growth Rate (2015-2025) Figure Global Microspheres/Nanosptheres Price (2015-2020) Figure Global Implants Sales Growth Rate (2015-2025) Figure Global Implants Price (2015-2020) Table Global Sustained Release Ocular Drug Delivery Systems Sales Market Share by Application (2015-2020) Figure Global Sustained Release Ocular Drug Delivery Systems Sales Market Share by Application in 2019 Figure Global Cataract Sales Growth Rate (2015-2025) Figure Global Glaucoma Sales Growth Rate (2015-2025) Figure Global Corneal Transplantation Sales Growth Rate (2015-2025) Figure Global Others Sales Growth Rate (2015-2025) Table Key Players of Upstream Markets Table Key Raw Materials Figure Price Trend of Key Raw Materials Table Key Suppliers of Raw Materials Figure Manufacturing Cost Structure of Sustained Release Ocular Drug Delivery Systems Table Key Players of Downstream Markets Figure Sales Channel Figure Global Sustained Release Ocular Drug Delivery Systems Production (K Units) Growth Rate Forecast (2020-2025) Figure Global Sustained Release Ocular Drug Delivery Systems Revenue (Million US$) Growth Rate Forecast (2020-2025) Figure Global Sustained Release Ocular Drug Delivery Systems Price and Trend Forecast (2020-2025) Table Global Sustained Release Ocular Drug Delivery Systems Sales (K Units) Forecast by Region (2020-2025) Figure Global Sustained Release Ocular Drug Delivery Systems Production Market Share Forecast by Region (2020-2025) Figure North America Sustained Release Ocular Drug Delivery Systems Sales (K Units) Growth Rate Forecast (2020-2025) Figure North America Sustained Release Ocular Drug Delivery Systems Revenue (Million US$) Growth Rate Forecast (2020-2025) Figure Europe Sustained Release Ocular Drug Delivery Systems Sales (K Units) Growth Rate Forecast (2020-2025) Figure Europe Sustained Release Ocular Drug Delivery Systems Revenue (Million US$) Growth Rate Forecast (2020-2025) Figure Japan Sustained Release Ocular Drug Delivery Systems Production (K Units) Growth Rate Forecast (2020-2025) Figure Japan Sustained Release Ocular Drug Delivery Systems Revenue (Million US$) Growth Rate Forecast (2020-2025) Figure China Sustained Release Ocular Drug Delivery Systems Production (K Units) Growth Rate Forecast (2020-2025) Figure China Sustained Release Ocular Drug Delivery Systems Revenue (Million US$) Growth Rate Forecast (2020-2025) Figure Methodology/Research Approach Figure Market Size Estimation Figure Author List

pSivida Allergan Icon Bioscience Ocular Therapeutix Neurotech Pharmaceuticals Santen Pharmaceutical Aciont Inc. Envisia Therapeutics GrayBug Innocore Pharmaceuticals OHR Pharmaceuticals